vs
Side-by-side financial comparison of National CineMedia, Inc. (NCMI) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $63.4M, roughly 1.2× National CineMedia, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 1.6%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-2.0M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -16.4%).
National CineMedia, Inc. (NCM) is an American cinema advertising company. NCM displays ads to U.S. consumers in movie theaters, online and through mobile technology. NCM presents cinema advertising across a digital in-theater network, consisting of theaters owned by AMC Theatres, Cinemark Theatres, Regal Cinemas and other regional theater circuits.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
NCMI vs PBYI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $63.4M | $75.5M |
| Net Profit | $1.6M | — |
| Gross Margin | 95.0% | 69.3% |
| Operating Margin | -2.8% | 22.7% |
| Net Margin | 2.5% | — |
| Revenue YoY | 1.6% | 27.7% |
| Net Profit YoY | 144.4% | — |
| EPS (diluted) | $0.02 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | $63.4M | $54.5M | ||
| Q2 25 | $51.8M | $52.4M | ||
| Q1 25 | $34.9M | $46.0M | ||
| Q4 24 | $86.3M | $59.1M | ||
| Q3 24 | $62.4M | $80.5M | ||
| Q2 24 | $54.7M | $47.1M | ||
| Q1 24 | $37.4M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $1.6M | $8.8M | ||
| Q2 25 | $-10.7M | $5.9M | ||
| Q1 25 | $-30.7M | $3.0M | ||
| Q4 24 | $24.7M | — | ||
| Q3 24 | $-3.6M | $20.3M | ||
| Q2 24 | $-8.7M | $-4.5M | ||
| Q1 24 | $-34.7M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | 95.0% | 77.7% | ||
| Q2 25 | 93.8% | 76.5% | ||
| Q1 25 | 91.1% | 77.1% | ||
| Q4 24 | 96.4% | 76.4% | ||
| Q3 24 | 94.7% | 63.9% | ||
| Q2 24 | 93.2% | 77.4% | ||
| Q1 24 | 90.4% | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | -2.8% | 17.6% | ||
| Q2 25 | -23.2% | 12.7% | ||
| Q1 25 | -68.5% | 8.7% | ||
| Q4 24 | 23.2% | 22.6% | ||
| Q3 24 | -12.0% | 27.4% | ||
| Q2 24 | -17.0% | -4.6% | ||
| Q1 24 | -60.7% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | 2.5% | 16.2% | ||
| Q2 25 | -20.7% | 11.2% | ||
| Q1 25 | -88.0% | 6.5% | ||
| Q4 24 | 28.6% | — | ||
| Q3 24 | -5.8% | 25.2% | ||
| Q2 24 | -15.9% | -9.6% | ||
| Q1 24 | -92.8% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.02 | $0.17 | ||
| Q2 25 | $-0.11 | $0.12 | ||
| Q1 25 | $-0.32 | $0.06 | ||
| Q4 24 | $0.26 | $0.40 | ||
| Q3 24 | $-0.04 | $0.41 | ||
| Q2 24 | $-0.09 | $-0.09 | ||
| Q1 24 | $-0.36 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $29.9M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $350.5M | $130.3M |
| Total Assets | $451.9M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | $29.9M | $94.4M | ||
| Q2 25 | $37.2M | $96.0M | ||
| Q1 25 | $59.8M | $93.2M | ||
| Q4 24 | $75.2M | $101.0M | ||
| Q3 24 | $49.5M | $96.7M | ||
| Q2 24 | $53.8M | $96.8M | ||
| Q1 24 | $57.1M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | $350.5M | $115.3M | ||
| Q2 25 | $350.0M | $104.7M | ||
| Q1 25 | $370.8M | $97.1M | ||
| Q4 24 | $411.2M | $92.1M | ||
| Q3 24 | $385.5M | $71.1M | ||
| Q2 24 | $387.9M | $48.5M | ||
| Q1 24 | $402.3M | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | $451.9M | $202.9M | ||
| Q2 25 | $462.0M | $194.9M | ||
| Q1 25 | $503.8M | $196.2M | ||
| Q4 24 | $568.6M | $213.3M | ||
| Q3 24 | $526.1M | $220.7M | ||
| Q2 24 | $527.2M | $205.0M | ||
| Q1 24 | $538.6M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.0M | $14.4M |
| Free Cash FlowOCF − Capex | $-2.0M | $14.4M |
| FCF MarginFCF / Revenue | -3.2% | 19.1% |
| Capex IntensityCapex / Revenue | 1.6% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.63× | — |
| TTM Free Cash FlowTrailing 4 quarters | $24.8M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-1.0M | $9.7M | ||
| Q2 25 | $-4.9M | $14.1M | ||
| Q1 25 | $6.0M | $3.6M | ||
| Q4 24 | $30.5M | $15.6M | ||
| Q3 24 | $-2.0M | $11.0M | ||
| Q2 24 | $7.7M | $1.0M | ||
| Q1 24 | $24.1M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-2.0M | $9.7M | ||
| Q2 25 | $-6.6M | $14.1M | ||
| Q1 25 | $5.3M | $3.6M | ||
| Q4 24 | $28.1M | $15.6M | ||
| Q3 24 | $-2.6M | $11.0M | ||
| Q2 24 | $6.4M | $1.0M | ||
| Q1 24 | $22.6M | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | -3.2% | 17.7% | ||
| Q2 25 | -12.7% | 26.8% | ||
| Q1 25 | 15.2% | 7.7% | ||
| Q4 24 | 32.6% | 26.4% | ||
| Q3 24 | -4.2% | 13.7% | ||
| Q2 24 | 11.7% | 2.1% | ||
| Q1 24 | 60.4% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 3.3% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 2.8% | 0.0% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 2.4% | 0.0% | ||
| Q1 24 | 4.0% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | -0.63× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 1.23× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NCMI
| National Advertising Revenue | $49.9M | 79% |
| Local Advertising Revenue | $9.6M | 15% |
| Founding Member Advertising Revenue From Beverage Concessionaire Agreements | $3.9M | 6% |
PBYI
Segment breakdown not available.
